Cargando…

Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes

Detalles Bibliográficos
Autores principales:	Alebouyeh, Masoud, Yadegar, Abbas, Farzi, Nastaran, Miri, Marzyieh, Zojaji, Homayoon, Gharibi, Somayeh, Fazeli, Zeinab, Ebrahimi Daryani, Naser, Asadzadeh Aghdaei, Hamid, Zali, Mohammad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495421/ https://www.ncbi.nlm.nih.gov/pubmed/26171132

Ejemplares similares

High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping
por: Farzi, Nastaran, et al.
Publicado: (2019)

Helicobacter pylori CagA induced interleukin-8 secretion in gastric epithelial cells
por: Fazeli, Zeinab, et al.
Publicado: (2016)

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors
por: Rezasoltani, Sama, et al.
Publicado: (2020)

The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications
por: Miri, Amir Hossein, et al.
Publicado: (2022)

Genetic diversity of Helicobacter pylori type IV secretion system cagI and cagN genes and their association with clinical diseases
por: Azizimoghaddam, Yasaman, et al.
Publicado: (2023)

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)

How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19?
por: Rezasoltani, Sama, et al.
Publicado: (2020)

Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR
por: Rezasoltani, Sama, et al.
Publicado: (2020)

Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Sensitivity to nitazoxanide among metronidazole resistant Helicobacter pylori strains in patients with gastritis
por: Baradaran Moghaddam, Ali, et al.
Publicado: (2016)

Modulation of microRNAs and claudin-7 in Caco-2 cell line treated with Blastocystis sp., subtype 3 soluble total antigen
por: Mohammad Rahimi, Hanieh, et al.
Publicado: (2022)

Management of multi-drug resistant Helicobacter pylori infection by supplementary, complementary and alternative medicine; a review
por: Rezaeimanesh, Nasim, et al.
Publicado: (2017)

Protein profiling of infected human gastric epithelial cells with an Iranian Helicobacter pylori clinical isolate
por: Fazeli, Zeinab, et al.
Publicado: (2017)

Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and gastroenteritis
por: Ganji, Leila, et al.
Publicado: (2016)

Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Effect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients
por: Dadaei, Tahereh, et al.
Publicado: (2015)

Evaluation of MALAT1 promoter DNA methylation patterns in early colorectal lesions and tumors
por: Chaleshi, Vahid, et al.
Publicado: (2019)

Association of lncRNA-p53 regulatory network (lincRNA-p21, lincRNA-ROR and MALAT1) and p53 with the clinicopathological features of colorectal primary lesions and tumors
por: Chaleshi, Vahid, et al.
Publicado: (2020)

Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran
por: Azimirad, Masoumeh, et al.
Publicado: (2019)

Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

The Necessity of Stool Examination in Asymptomatic Carriers as a Strategic Measure to Control Further Spread of SARS-CoV-2
por: Mirjalali, Hamed, et al.
Publicado: (2020)

Expression of Main Toll-Like Receptors in Patients with Different Types of Colorectal Polyps and Their Relationship with Gut Microbiota
por: Rezasoltani, Sama, et al.
Publicado: (2020)

Expression of Toll-Like Receptors 2, 4 and 5 in Relation to Gut Microbiota in Colon Neoplasm Patients with and without Inflammatory Bowel Disease
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2022)

Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model
por: Abdolahi, Shahrokh, et al.
Publicado: (2021)

Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021)

Novel Therapeutic Strategies for Celiac Disease
por: Asri, Nastaran, et al.
Publicado: (2020)

Investigation and characterization of human gut phageome in advanced liver cirrhosis of defined etiologies
por: Naseri, Mohadeseh, et al.
Publicado: (2022)

Association of Helicobacter pylori with central serous chorioretinopathy in Iranian patients
por: Roshani, Mohammad, et al.
Publicado: (2014)

Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection
por: Mascellino, Maria Teresa, et al.
Publicado: (2017)

Characteristics of Helicobacter pylori Heteroresistance in Gastric Biopsies and Its Clinical Relevance
por: Wang, You-hua, et al.
Publicado: (2022)

Occurrence of Helicobacter pylori and its major virulence genotypes in dental plaque samples of patients with chronic periodontitis in Iran
por: Valadan Tahbaz, Sahel, et al.
Publicado: (2017)

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Comprehensive Study of Phenotypic and Growth Rate Features of Blastocystis Subtypes 1–3 and 6 in Symptomatic and Asymptomatic Subjects
por: KARAMATI, Seyed Ahmad, et al.
Publicado: (2019)

Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients
por: Makhmalbaf, Mobin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4gqp0c4e5sv0emnt23ghflat2e